Context Therapeutics Inc. (CNTX)
Largest Insider Buys in Sector
CNTX Stock Price History Chart
CNTX Stock Performance
About Context Therapeutics Inc.
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Insider Activity of Context Therapeutics Inc.
Over the last 12 months, insiders at Context Therapeutics Inc. have bought $0 and sold $0 worth of Context Therapeutics Inc. stock.
On average, over the past 5 years, insiders at Context Therapeutics Inc. have bought $81,767 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 5,823 shares for transaction amount of $4,900 was made by Lehr Martin A. (Chief Executive Officer) on 2023‑02‑21.
List of Insider Buy and Sell Transactions, Context Therapeutics Inc.
| 2023-02-21 | Chief Executive Officer | 5,823 0.0382% | $0.84 | $4,900 | +28.27% | |||
| 2023-02-13 | Chief Executive Officer | 5,606 0.0365% | $0.87 | $4,901 | +22.47% | |||
| 2023-02-06 | Chief Executive Officer | 5,040 0.032% | $0.97 | $4,900 | +6.26% | |||
| 2023-01-30 | Chief Executive Officer | 7,027 0.0449% | $0.70 | $4,901 | +49.34% | |||
| 2023-01-23 | Chief Executive Officer | 6,839 0.0434% | $0.72 | $4,901 | +44.27% | |||
| 2023-01-17 | Chief Executive Officer | 6,783 0.0442% | $0.74 | $4,995 | +41.95% | |||
| 2022-12-16 | Chief Executive Officer | 20,000 0.1253% | $0.74 | $14,796 | +24.32% | |||
| 2022-12-16 | Chief Financial Officer | 25,000 0.1566% | $0.74 | $18,500 | +24.32% | |||
| 2022-12-09 | Chief Legal Officer, Corp. Sec | 6,000 0.0384% | $0.85 | $5,095 | +9.88% | |||
| 2022-08-19 | Chief Executive Officer | 13,000 0.0824% | $1.85 | $24,064 | -43.17% | |||
| 2022-08-17 | Chief Financial Officer | 15,000 0.0939% | $1.80 | $27,000 | -41.94% | |||
| 2022-08-16 | Chief Medical Officer | 10,000 0.0636% | $1.95 | $19,500 | -45.18% | |||
| 2021-12-16 | Chief Executive Officer | 13,000 0.4558% | $3.22 | $41,850 | -41.36% | |||
| 2021-10-22 | Chief Executive Officer | 10,000 0.2524% | $5.00 | $50,000 | -71.82% | |||
| 2021-10-22 | Chief Legal Officer, Corp. Sec | 3,000 0.0757% | $5.00 | $15,000 | -71.82% |
Insider Historical Profitability
| Lehr Martin A. | Chief Executive Officer | 159701 0.2129% | $1.47 | 10 | 0 | +6.05% |
| Minai-Azary Jennifer Lynn | Chief Financial Officer | 40000 0.0533% | $1.47 | 2 | 0 | <0.0001% |
| Sahmoud Tarek | Chief Medical Officer | 10000 0.0133% | $1.47 | 1 | 0 | <0.0001% |
| Levit Alex C. | Chief Legal Officer, Corp. Sec | 9000 0.012% | $1.47 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
| Opaleye Management Inc | $1.53M | 1.48 | 1.11M | +13.68% | +$184,032.70 | 0.34 | |
| Ally Bridge Group | $1M | 0.97 | 725,951 | 0% | +$0 | 0.56 | |
| The Vanguard Group | $825,658.00 | 0.8 | 598,303 | +0.38% | +$3,161.58 | <0.0001 | |
| Affinity Asset Advisors | $453,767.00 | 0.44 | 328,817 | 0% | +$0 | 0.01 | |
| Ubs Oconnor Llc | $409,412.00 | 0.4 | 296,675 | 0% | +$0 | 0.02 | |
| Hightower Advisors | $174,000.00 | 0.17 | 125,852 | 0% | +$0 | <0.0001 | |
| Bridgeway Capital Management | $146,016.00 | 0.14 | 105,809 | 0% | +$0 | <0.01 | |
| Mill Creek Capital Advisors Llc | $144,391.00 | 0.14 | 104,631 | 0% | +$0 | <0.01 | |
| Geode Capital Management | $139,547.00 | 0.14 | 101,072 | +3.94% | +$5,290.72 | <0.0001 | |
| Renaissance Technologies | $55,000.00 | 0.05 | 39,900 | +23.91% | +$10,614.03 | <0.0001 | |
| Northern Trust | $51,362.00 | 0.05 | 37,219 | 0% | +$0 | <0.0001 | |
| Clear Harbor Asset Management | $49,680.00 | 0.05 | 36,000 | 0% | +$0 | <0.01 | |
| State Street | $45,412.00 | 0.04 | 32,907 | 0% | +$0 | <0.0001 | |
| Susquehanna International Group | $30,897.00 | 0.03 | 22,389 | New | +$30,897.00 | <0.0001 | |
| Sheets Smith Wealth Management, Inc. | $27,600.00 | 0.03 | 20,000 | 0% | +$0 | <0.01 | |
| Citadel Advisors LLC | $20,757.00 | 0.02 | 15,041 | -5.28% | -$1,157.84 | <0.0001 | |
| Jefferies Financial Group | $15,805.00 | 0.02 | 11,453 | New | +$15,805.00 | <0.0001 | |
| Xtx Topco Ltd | $14,160.00 | 0.01 | 10,261 | New | +$14,160.00 | <0.0001 | |
| Tower Research Capital | $8,773.00 | 0.01 | 6,357 | -4.48% | -$411.26 | <0.0001 | |
| Advisor Group Holdings Inc | $2,070.00 | <0.01 | 1,500 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $160.00 | <0.01 | 116 | +1.75% | +$2.76 | <0.0001 | |
| Retirement Group Llc | $214.00 | <0.01 | 155 | 0% | +$0 | <0.0001 | |
| JPMorgan Chase | $46.00 | <0.01 | 33 | +43.48% | +$13.94 | <0.0001 |